Related Experiment Video
Updated: Aug 6, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes
John M Lachin1, Ionut Bebu2, Richard M Bergenstal3
1The Biostatistics Center, The George Washington University, Rockville, MD jml@bsc.gwu.edu.
Insights
Glycemic variability within a day did not significantly impact microvascular complications in type 1 diabetes. Mean blood glucose levels were the primary factor influencing these diabetes complications.
Area of Science:
- Endocrinology
- Diabetology
- Clinical Research
Background:
- The Diabetes Control and Complications Trial (DCCT) established that intensive therapy reduces microvascular complications in type 1 diabetes.
- These benefits were largely attributed to improved HbA1c levels, which correlate with complication risk.
Purpose of the Study:
- To investigate the association between glucose variability and the development/progression of retinopathy, nephropathy, and cardiovascular autonomic neuropathy.
- To determine if within-day and between-day glucose fluctuations impact microvascular complications independently of mean glucose levels.
Main Methods:
- Analysis of quarterly 7-point glucose profiles from the DCCT.
- Utilized measures of glucose variability including SD, MAGE, and M-value.
- Employed Cox proportional hazards and longitudinal logistic regression models, adjusting for mean blood glucose.
Main Results:
- No significant association was found between within-day glycemic variability and any microvascular complication when adjusted for mean blood glucose.
- Only the longitudinal mean M-value showed a significant association with microalbuminuria after adjustment and correction for multiple testing.
Conclusions:
- Within-day glucose variability, assessed from quarterly profiles, does not appear to be an independent risk factor for microvascular complications in type 1 diabetes.
- Mean glucose level remains the dominant factor influencing the development of these complications.
Objective:
The Diabetes Control and Complications Trial (DCCT) demonstrated the beneficial effects of intensive versus conventional therapy on the development and progression of microvascular complications of type 1 diabetes. These beneficial effects were almost completely explained by the difference between groups in the levels of HbA1c, which in turn were associated with the risk of these complications. We assessed the association of glucose variability within and between quarterly 7-point glucose profiles with the development and progression of retinopathy, nephropathy, and cardiovascular autonomic neuropathy during the DCCT.
Research Design And Methods:
Measures of variability included the within-day and updated mean (over time) of the SD, mean amplitude of glycemic excursions (MAGE), and M-value, and the longitudinal within-day, between-day, and total variances. Imputation methods filled in the 16.3% of expected glucose values that were missing.
Results:
Cox proportional hazards models assessed the association of each measure of glycemic variation, as a time-dependent covariate, with the risk of retinopathy and nephropathy, and a longitudinal logistic regression model did likewise for cardiovascular autonomic neuropathy. Adjusted for mean blood glucose, no measure of within-day variability was associated with any outcome. Only the longitudinal mean M-value (over time) was significantly associated with microalbuminuria when adjusted for the longitudinal mean blood glucose and corrected for multiple tests using the Holm procedure.
Conclusions:
Overall, within-day glycemic variability, as determined from quarterly glucose profiles, does not play an apparent role in the development of microvascular complications beyond the influence of the mean glucose.
More Related Videos
04:36An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy